ArticleClinical and translational science2021

Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.

Joseph Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.